Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies (Q41177029)

27 September 2017

title

Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies (English)

1 reference

27 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800010%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Alain Van Dorsselaer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800010%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Hélène Diemer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800010%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Elsa Wagner-Rousset

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800010%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Alain Beck

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800010%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

François Debaene

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800010%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Olivier Colas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800010%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

1 February 2015

1 reference

Journal of Mass Spectrometry

27 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800010%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800010%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800010%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

285-297

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800010%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference

21 January 2018

1 reference

European Medicines Agency workshop on biosimilar monoclonal antibodies: July 2, 2009, London, UK

21 January 2018

1 reference

Approval of the first biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry

21 January 2018

1 reference

Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies

21 January 2018

1 reference

Strategies and challenges for the next generation of therapeutic antibodies

21 January 2018

1 reference

9th annual European Antibody Congress, November 11-13, 2013, Geneva, Switzerland

21 January 2018

1 reference

Hearing shines spotlight on biosimilar controversies

21 January 2018

1 reference

Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies

21 January 2018

1 reference

Comparability analysis of anti-CD20 commercial (rituximab) and RNAi-mediated fucosylated antibodies by two LC-MS approaches

21 January 2018

1 reference

Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products

21 January 2018

1 reference

Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques.

21 January 2018

1 reference

Characterization of therapeutic antibodies and related products.

21 January 2018

1 reference

Electrospray ionization quadrupole ion-mobility time-of-flight mass spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the therapeutic monoclonal antibody trastuzumab.

21 January 2018

1 reference

Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequentia

21 January 2018

1 reference

An innovative approach for the characterization of the isoforms of a monoclonal antibody product

21 January 2018

1 reference

Unambiguous characterization of N-glycans of monoclonal antibody cetuximab by integration of LC-MS/MS and ¹H NMR spectroscopy

21 January 2018

1 reference

Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose

21 January 2018

1 reference

GlycoFi's technology to control the glycosylation of recombinant therapeutic proteins

21 January 2018

1 reference

Phase 1 study of anti-epidermal growth factor receptor monoclonal antibody in patients with solid tumors

21 January 2018

1 reference

Human immunoglobulin allotypes: possible implications for immunogenicity

21 January 2018

1 reference

Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells

21 January 2018

1 reference

Method to convert N-terminal glutamine to pyroglutamate for characterization of recombinant monoclonal antibodies

21 January 2018

1 reference

Rapid and multi-level characterization of trastuzumab using sheathless capillary electrophoresis-tandem mass spectrometry.

21 January 2018

1 reference

Hydrogen/deuterium exchange mass spectrometry for probing higher order structure of protein therapeutics: methodology and applications

21 January 2018

1 reference

Investigating monoclonal antibody aggregation using a combination of H/DX-MS and other biophysical measurements

21 January 2018

1 reference

Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS.

21 January 2018

1 reference

Mass spectrometric analysis of intact human monoclonal antibody aggregates fractionated by size-exclusion chromatography.

21 January 2018

1 reference

Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and "bispecific" monoclonal antibody formation

21 January 2018

1 reference

Resolving disulfide structural isoforms of IgG2 monoclonal antibodies by ion mobility mass spectrometry

21 January 2018

1 reference

Middle-down analysis of monoclonal antibodies with electron transfer dissociation orbitrap fourier transform mass spectrometry.

21 January 2018

1 reference

Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody.

21 January 2018

1 reference

Glycosylation as a strategy to improve antibody-based therapeutics

21 January 2018

1 reference

Understanding the conformational impact of chemical modifications on monoclonal antibodies with diverse sequence variation using hydrogen/deuterium exchange mass spectrometry and structural modeling

21 January 2018

1 reference

The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies

21 January 2018

1 reference

Conformational characterization of the charge variants of a human IgG1 monoclonal antibody using H/D exchange mass spectrometry

21 January 2018

1 reference

Physicochemical and functional comparability between the proposed biosimilar rituximab GP2013 and originator rituximab

21 January 2018

1 reference

Detailed mass analysis of structural heterogeneity in monoclonal antibodies using native mass spectrometry

21 January 2018

1 reference

Dynamics of Intact Immunoglobulin G Explored by Drift-Tube Ion-Mobility Mass Spectrometry and Molecular Modeling

21 January 2018

1 reference

From high- to super-resolution mass spectrometry

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.2533/CHIMIA.2014.168